Difference between revisions of "Talk:20.109(S17):Module 2"
From Course Wiki
(→References from Prof. Samson Lecture 8) |
(→References from Prof. Samson Lecture 8) |
||
Line 6: | Line 6: | ||
*[[Media:Adachi et al BioChem 2003.pdf| Hypersensitivity of Nonhomologous DNA End-joining Mutants to VP-16 and ICRF-193.]] | *[[Media:Adachi et al BioChem 2003.pdf| Hypersensitivity of Nonhomologous DNA End-joining Mutants to VP-16 and ICRF-193.]] | ||
*[[Media:Engineered BRCA2mutations Invitrogen.pdf| Compound screening in BRCA2 (–/–) GeneArt Engineered Cell Model.]] | *[[Media:Engineered BRCA2mutations Invitrogen.pdf| Compound screening in BRCA2 (–/–) GeneArt Engineered Cell Model.]] | ||
+ | *[[Media:Lin et al PLOS 2009.pdf| p63 and p73 Transcriptionally Regulate Genes Involved in DNA Repair.]] | ||
+ | *[[Media:Nagel et al PNAS 2014.pdf| Multiplexed DNA repair assays for multiple lesions and multiple doses via transcription inhibition and transcriptional mutagenesis.]] | ||
+ | *[[Media:Treszezamsky et al CanRes 2007.pdf| BRCA1- and BRCA2-Deficient Cells Are Sensitive to Etoposide-Induced DNA Double-Strand Breaks via Topoisomerase II.]] | ||
==CellTiter Glo luminescence cell viability assay== | ==CellTiter Glo luminescence cell viability assay== |
Revision as of 19:37, 13 April 2017
Contents
References from Prof. Samson Lecture 8
- A syngeneic variance library for functional annotation of human variation: application to BRCA2.
- Hypersensitivity of Nonhomologous DNA End-joining Mutants to VP-16 and ICRF-193.
- Compound screening in BRCA2 (–/–) GeneArt Engineered Cell Model.
- p63 and p73 Transcriptionally Regulate Genes Involved in DNA Repair.
- Multiplexed DNA repair assays for multiple lesions and multiple doses via transcription inhibition and transcriptional mutagenesis.
- BRCA1- and BRCA2-Deficient Cells Are Sensitive to Etoposide-Induced DNA Double-Strand Breaks via Topoisomerase II.
CellTiter Glo luminescence cell viability assay
Western blot images
Instructor's Western Blot
T/R Western Blots